ACET FY 2011 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$68M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$412M+19.0% YoY

Gross Profit

$66M16.0% margin

Operating Income

$17M4.0% margin

Net Income

$9M2.2% margin

EPS (Diluted)

$6.24

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$295M

Total Liabilities

$151M

Stockholders' Equity

$161M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$412M	$347M	+19.0%
Gross Profit	$66M	$54M	+21.6%
Operating Income	$17M	$9M	+75.4%
Net Income	$9M	$7M	+36.3%